U.S. markets close in 5 hours 26 minutes

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.70+0.15 (+2.29%)
As of 10:34AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 5/16/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 0.66
52-Week Change 3-53.78%
S&P500 52-Week Change 341.30%
52 Week High 333.79
52 Week Low 35.81
50-Day Moving Average 37.87
200-Day Moving Average 310.18

Share Statistics

Avg Vol (3 month) 310.57M
Avg Vol (10 day) 39.29M
Shares Outstanding 5209.4M
Implied Shares Outstanding 6N/A
Float 205.9M
% Held by Insiders 11.69%
% Held by Institutions 134.85%
Shares Short (Apr 29, 2021) 454.46M
Short Ratio (Apr 29, 2021) 44.59
Short % of Float (Apr 29, 2021) 426.45%
Short % of Shares Outstanding (Apr 29, 2021) 426.01%
Shares Short (prior month Mar 30, 2021) 454.64M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Jun 05, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-2,345.51%

Management Effectiveness

Return on Assets (ttm)-19.04%
Return on Equity (ttm)-49.06%

Income Statement

Revenue (ttm)6.46M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)-72.00%
Gross Profit (ttm)-86.83M
EBITDA -147.97M
Net Income Avi to Common (ttm)-188.27M
Diluted EPS (ttm)-1.08
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)518.6M
Total Cash Per Share (mrq)2.48
Total Debt (mrq)33.9M
Total Debt/Equity (mrq)5.83
Current Ratio (mrq)14.17
Book Value Per Share (mrq)2.78

Cash Flow Statement

Operating Cash Flow (ttm)-205.39M
Levered Free Cash Flow (ttm)-130.03M